The WHO granted emergency use listing to the Tianjin-based firm's Convidecia vaccine as China battles a resurgence of the virus triggered by the Omicron variant.Convidecia was found to have 64 per cent efficacy against symptomatic disease and 92 per cent efficacy against severe Covid-19, the WHO said.
The WHO has now given EUL status to nine Covid-19 vaccines and variations thereof — Pfizer/BioNTech, AstraZeneca, Janssen, Moderna, Sinovac, Sinopharm, Bharat Biotech, Novavax and now CanSinoBIO.The WHO says EUL approval gives countries, funders, procuring agencies and communities assurance that the vaccine has met international standards.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: